The latest price list of larotrectinib

In the field of anti-tumor drugs, Larotrectinib has attracted widespread attention due to its unique mechanism and significant therapeutic effect. This article will introduce the latest price list of larotrectinib in detail from the two dimensions of original drugs and generic drugs, and discuss its drug characteristics and adverse reactions, with a view to providing a reference for patients and medical workers.

LarotrectinibOriginal drug price overview

As a world-renowned pharmaceutical company, Germany's Bayer produces capsules and oral solutions, which occupy an important position in the market. According to the latest price list, Bayer's larotrectinib capsules are divided into two specifications: 25mg 56 tablets and 100mg 56 tablets, with prices of 15,340$ per box and 52,000$ per box respectively. This price reflects the high investment in R&D, production and quality control of the original drug, and also reflects its unique value as an innovative drug.

In addition, Bayer also launched larotrectinib oral solution, with a specification of 20mg/ml and a price of 18,228$ per box. The oral solution provides convenience for patients who are unable to swallow capsules or require more flexible dosage adjustments, further enriching the dosage form of larotrectinib.

Generic drug price comparison

With the end of the patent protection period, many pharmaceutical companies have begun to produce generic versions of larotrectinib, entering the market at lower prices, providing patients with more choices. Among them, the generic version of larotrectinib from Everest Pharmaceuticals in Bangladesh is available in 100 mg and 30 capsules, and the price is $4,520 per box, which is highly cost-effective. Similar products from Bangladesh Yaopin International are slightly better at $4,000 per box, further reducing the financial burden on patients. The generic drug of Larotinib from Lucius in Laos is more affordable, with 30 capsules of 100mg costing only $1,950 per box, bringing good news to patients with limited financial conditions.

Adverse reactions and precautions

Although larotrectinib has shown significant efficacy in the treatment of specific types of tumors, a series of adverse reactions may also occur during its use. Common adverse reactions include nausea, dizziness, vomiting, cough, etc. Some patients may also experience serious reactions such as neurotoxicity, hepatotoxicity and embryo-fetal toxicity. Therefore, when using larotrectinib, patients should strictly follow medical instructions, conduct regular liver function and neurological examinations, and pay attention to observing body reactions. Once discomfort occurs, the doctor should be informed immediately so that the treatment plan can be adjusted or corresponding measures can be taken in a timely manner.

For patients with neurotoxicity, they should avoid driving or operating dangerous machinery to avoid accidents. Doctors will also adjust the dosage or take other measures based on the patient's specific situation to reduce the impact of adverse reactions.